A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor

Theresa Barberi, Rahila Khuroo, Alan D Friedman · 2026

Read A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor by Theresa Barberi, Rahila Khuroo, Alan D Friedman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355841.txt.

Description

Theresa Barberi, Rahila Khuroo, and Alan Friedman report in 2026 on a new line of lab mice. The mice were built to help test immune treatments for human cancers. Those treatments target a growth signal protein found on many tumours. Normal mice reject the human form of that protein. So the team made mice that carry a short human version. Their bodies accept it as their own.

The mice stayed tolerant even after the gene was switched off in adults. They also accepted mouse tumours carrying the same marker. Blood cells carried the marker strongly. Levels were lower in the liver, lung, kidney, and brain. A known antibody still binds the short form. The line offers a safer test bed for such treatments.

Catalog record

CREATORTheresa Barberi, Rahila Khuroo, Alan D Friedman
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23836
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0355841

Browse the full library · About the Tower of Babel